A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation ...

There are a small group of people in the world who carry a unique feature in their DNA: a genetic mutation called ISG15 that ...

Deficiencies in interferon-stimulated gene 15 (ISG15), a protein that normally regulates the immune response, causes mild but persistent inflammation. However, its absence also provides an unexpected ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Scientists at Columbia University are developing a universal antiviral. This treatment aims to protect against many viruses, including influenza and COVID-19. The therapy is inspired by a rare genetic ...

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising ...

In what sounds like the plot from a sci-fi movie, scientists have isolated an incredibly rare immune mutation to create a universal antiviral treatment. Only present in a few dozen people ...

Scientists created mRNA inhaler that makes cells produce antiviral proteins. It protected cells from flu and Zika, and ...

Health experts say the best time to get a COVID booster shot is in the early fall, with mid-September through October ...

Despite current warning labels, oseltamivir is not linked to increased risk for neuropsychiatric events in pediatric patients ...

There are two antiviral pills authorized by the U.S. Food and Drug Administration to treat COVID-19 at home: Pfizer's Paxlovid for people 12 and older, and Merck's molnupiravir for adults.